Results 231 to 240 of about 24,774 (261)
Some of the next articles are maybe not open access.
Biochemical and Biophysical Research Communications, 1993
In the present study the cDNA of human beta ARK2 was cloned using both PCR and cDNA library screening, subcloned into an expression vector and transiently expressed in COS7 cells. The expressed kinase activity was approximately 40% as efficient as human beta ARK1 in phosphorylating bovine rod outer segments in vitro. Northern blot analysis of human and
Parruti G +3 more
openaire +2 more sources
In the present study the cDNA of human beta ARK2 was cloned using both PCR and cDNA library screening, subcloned into an expression vector and transiently expressed in COS7 cells. The expressed kinase activity was approximately 40% as efficient as human beta ARK1 in phosphorylating bovine rod outer segments in vitro. Northern blot analysis of human and
Parruti G +3 more
openaire +2 more sources
Serum creatine kinase release and alpha- and beta-adrenergic receptors.
Archives internationales de pharmacodynamie et de therapie, 1986Changes in the serum creatine kinase (CK) activity and the mechanism of its release after administration of two kinds of beta-blockers to rats were studied in order to determine the mechanism of the increase in serum CK accompanying administration of beta-blockers.
Y, Jingu, Y, Aoki, H, Itoh, T, Saruta
openaire +1 more source
Carondiac G-Protein Receptor Kinase Activity: Effect of a β-Adrenergic Receptor Antagonist
1997Publisher Summary This chapter presents a summary of the data that test the hypothesis that β -adrenergic receptor ( β AR) activation affects G-protein receptor kinase (GRK) activity in the heart. Data reported in the chapter have been previously published. The chapter has attempted to summarize the key features of this publication. Selected figures
H K, Hammond, P, Ping, P A, Insel
openaire +2 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly